Home / Import refusals / 1FX-7030224-4/10002/1

FDA Import Refusal 1FX-7030224-4/10002/1 — Glaxo India

Glaxo India — FEI 3000146207

The FDA refused shipment 1FX-7030224-4/10002/1 from Glaxo India (India) on June 1, 2026. The refused product falls under Drugs and Biologics — ALLOPURINOL (XANTHINE OXIDASE INHIBITOR). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 1, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
66TCY01 ALLOPURINOL (XANTHINE OXIDASE INHIBITOR)
Charges
75

Other import refusals

  • 799-6241705-2/11/1 (Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6241705-2/71/1 (Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6241705-2/71/2 (Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9303794-3/11/1 (Wed Jun 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4874980-4/1/2 (Fri Apr 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources